Researchers at the Indian Institute of Science have discovered how inherent variations and interactions with surroundings influence cancer cell migration. By studying ovarian cancer cell types on ...
The phase 3 SKYSCRAPER-01 trial of tiragolumab and atezolizumab in PD-L1-high non–small cell lung cancer did not meet its primary end point of overall survival.